top of page
  • Writer's pictureCheckers

OPTI Enters Redemption Arc: New Leadership Has Big Plans

In the dynamic world of over-the-counter (OTC) markets, mergers and acquisitions always create a buzz, captivating investors with the potential for promising returns. At the forefront of this excitement this week is OPTI, a ticker that's become the center of one of the market's most intriguing stories. With a new company set to join its ranks, OPTI's stock, which previously soared to 50 cents in 2021, is under the spotlight once again.


But the narrative behind OPTI goes a bit further than just your average OTC merger: it's a tale of redemption for one of its main investors – and OPTI shareholders everywhere. The company's history is marked by a tumultuous period under the former CEO who, after overseeing the stock hit impressive heights, threw shareholders into dismay as they were left holding the bag. This move not only impacted investor trust but also paved the way for a dramatic takeover.


Brett Rosen, a well-known name as a result of his numerous investments in the OTC through his company RB Capital Partners, has recently become a central figure in the unfolding narrative of OPTI. Following a legal dispute rooted in significant debts owed to his firm, Rosen has catalyzed a dramatic management overhaul. This move is particularly noteworthy given Rosen's reputation for invigorating companies on the OTC, prompting speculation about OPTI's potential resurgence.


In a direct communication with investors, Brett Rosen used his personal Twitter account to engage with the OPTI community, promising updates and declaring his commitment to the company's turnaround:



Yesterday the press release from Brett Rosen’s RB Capital Partners was released, which confirmed they won a landmark legal victory over the company's former CEO. The press release highlighted a series of legal proceedings aimed at addressing the CEO’s self-dealing, mismanagement, and asset dilution. These proceedings reached a climax last November when a court ruled in favor of RB Capital Partners, awarding a substantial $14.6 million judgment against previous management and the company. The verdict imposes strict limitations on the previous CEO’s future involvement with OPTI while also granting RB Capital the authority to appoint new leadership, marking a pivotal step towards the company's overhaul and signifying a new chapter of redemption for OPTI.


Admidst this backdrop, OPTI's standing in the unpredictable OTC market is strengthened by its maxed-out share structure, which naturally mitigates the risk of dilution, a frequent investor concern. Brett Rosen has further bolstered investor confidence in this with the announcement of a strategic $5 million buyback program, aimed at reducing the outstanding share count.



Revealed in the above tweet following the press release and reiterated in this interview done live by @buffalofireside, the buyback initiative reflects Rosen's belief in OPTI's inherent value and promising future. Alongside the buyback, Rosen plans to advance other share structure optimization efforts to further refine and strengthen OPTI's capital framework. All these moves together means there are minimal lingering concerns about share dilution for investors.

In the same interview last night, Brett Rosen emphasized a key element of his plan to increase shareholder value at OPTI: the search for an appropriate merger candidate. He disclosed that OPTI is carefully assessing four potential merger targets, each with up to $100 million in revenues. This effort is pivotal to OPTI's revitalization, focusing on integrating a business that can significantly boost its value and market standing. It's a strategic move designed to reinforce the company's foundation and enhance shareholder value.


This juncture for OPTI, marked by strategic legal victories and leadership shifts, heralds a significant new chapter in its story. More than just a narrative of financial recovery, it's a testament to the resilience of its shareholders, the strategic maneuvering of its new leadership, and a collective drive towards redemption. As OPTI embarks on this path, with strategic mergers and a solidified share structure in its sights, the anticipation among investors and the broader market is palpable. This period for OPTI is all about a renewed commitment to growth, stability, and shareholder value in the evolving landscape of the OTC market.


Keep your eyes out over the next couple weeks for further updates on OPTI from Brett Rosen on Twitter, @BrettRosen325.



369 views0 comments

Comments


bottom of page